Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec 7;100(23):2308-11.
doi: 10.1161/01.cir.100.23.2308.

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a

Affiliations

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a

del MonteF et al. Circulation. .

Abstract

Background: Failing human myocardium is characterized by abnormal relaxation, a deficient sarcoplasmic reticulum (SR) Ca(2+) uptake, and a negative frequency response, which have all been related to a deficiency in the SR Ca(2+) ATPase (SERCA2a) pump.

Methods and results: To test the hypothesis that an increase in SERCA2a could improve contractile function in cardiomyocytes, we overexpressed SERCA2a in human ventricular myocytes from 10 patients with end-stage heart failure and examined intracellular Ca(2+) handling and contractile function. Overexpression of SERCA2a resulted in an increase in both protein expression and pump activity and induced a faster contraction velocity (26.7+/-6.7% versus 16.6+/-2.7% shortening per second, P<0.005) and enhanced relaxation velocity (32. 0+/-10.1% versus 15.1+/-2.4%, P<0.005). Diastolic Ca(2+) was decreased in failing cardiomyocytes overexpressing SERCA2a (270+/-26 versus 347+/-30 nmol/L, P<0.005), whereas systolic Ca(2+) was increased (601+/-38 versus 508+/-25 nmol/L, P<0.05). In addition, the frequency response was normalized in cardiomyocytes overexpressing SERCA2a.

Conclusions: These results support the premise that gene-based therapies and targeting of specific pathways in human heart failure may offer a new modality for the treatment of this disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a, After isolation, failing human cardiomyocytes were infected with Ad.SERCA2a. Twenty-four hours after infection, a cardiomyocyte is visualized with white light and at 510 nm with single excitation peak at 490 nm of blue light. Coexpression of GFP demonstrates visually that SERCA2a is being expressed in cell. b, Recordings from cardiomyocytes isolated from donor nonfailing heart and from failing heart infected with either Ad.GFP or Ad.SERCA2a, stimulated at 1 Hz at 37°C. Failing cell had a characteristic decrease in contraction and prolonged relaxation along with a prolonged Ca2+ transient. Overexpression of SERCA2a in failing cardiomyocyte normalized these parameters. c, Recordings from same cardiomyocytes as in b stimulated at increasing frequencies. Failing cardiomyocyte demonstrated a decrease in contraction amplitude and an increase in diastolic tone and Ca2+. Overexpression of SERCA2a restored frequency-dependent increase in contraction amplitude and mitigated increase in diastolic Ca2+ and length.
Figure 2
Figure 2
a, Immunoblots of SERCA2a from crude membranes of failing cardiomyocytes infected for 24 hours with Ad.SERCA2a or Ad.GFP. All representative lanes are from failing hearts. Each pair of immunoreactive densities represents paired immunoblots from 1 preparation of failing cardiomyocytes that were infected with either Ad.GFP or Ad.SERCA2a. b, Paired measurements of ATPase activity performed at [Ca2+] of 10 μmol/L in membrane preparations from failing cardiomyocytes infected for 24 hours with Ad.SERCA2a or Ad.GFP.

Comment in

Similar articles

Cited by

References

    1. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 1994;74:555–564. - PubMed
    1. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70–76. - PubMed
    1. Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM, Morgan JP. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest. 1990;85:1599–1613. - PMC - PubMed
    1. Harding SE, Jones SM, O’Gara P, del Monte F, Vescovo G, Poole-Wilson PA. Isolated ventricular myocytes from failing and non-failing human heart: the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol. 1992;24:549–564. - PubMed
    1. del Monte F, O’Gara P, Poole-Wilson PA, Yacoub M, Harding SE. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res. 1995;30:281–290. - PubMed

Publication types

MeSH terms